Background: Trimethoprim-sulfamethoxazole (TMP-SMX) has long been considered the treatment of choice for infections caused by Stenotrophomonas maltophilia. Levofloxacin has emerged as a potential option for treating these infections. This study aimed to evaluate the clinical outcomes in patients who received TMP-SMX versus levofloxacin for treating S.
View Article and Find Full Text PDFBackground: The aim of this study was to compare the safety and effectiveness of monotherapy versus combination therapy for the treatment of infections caused by .
Methods: This retrospective, multicenter, cohort study included patients treated with either monotherapy or combination therapy for infections caused by . Primary outcomes included overall in-hospital mortality, 30-day mortality, and clinical cure.
Objectives: To evaluate pharmacy students' nontechnical skills in a simulated session by assessing their teamwork skills and ability to identify patient safety priorities.
Methods: This study involved 2 phases. Phase I was a simulated case with a total of 23 errors.
Purpose: This research aimed, first, to identify, summarize, and synthesize the studies reporting the development, translation, and/or psychometric evaluation of PROMs in Arabic-speaking populations and, second, to evaluate the psychometric properties and the translation process of a sample 26 PROMs.
Methods: In 2019, PubMed, Web of Science, and SCOPUS were searched for studies reporting the development, translation, or cross-cultural adaptation of patient-reported outcome measures in Arabic-speaking populations, and those including the assessment of one or more psychometric properties as PROMs (including validity, reliability, responsiveness, interpretability) in our target populations were included. The review protocol registration number is CRD42018088991.